| The systemic inflammation response index: an independent predictive factor for survival outcomes of bladder cancer stronger than other inflammatory markers H Yilmaz, NB Cinar, IE Avci, E Telli, AK Uslubas, K Teke, O Dillioglugil Urologic Oncology: Seminars and Original Investigations 41 (5), 256. e1-256. e8, 2023 | 7 | 2023 |
| Oncological and functional outcomes of patients who underwent open partial nephrectomy for kidney tumor E Bosnalı, EA Baynal, NB Çınar, EM Akdas, E Telli, BY Bayrak, K Teke, ... Archivio Italiano di Urologia e Andrologia 95 (4), 2023 | 1 | 2023 |
| The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse … EM Akdaş, MM Çulha, E Telli, E Bosnalı, S Baykal, EA Baynal, K Teke, ... International Urology and Nephrology, 1-7, 2024 | | 2024 |
| The role of immunotherapy in urological cancers E Bosnali, EM Akdas, E Telli, K Teke, O Kara Archivio Italiano di Urologia e Andrologia, 2024 | | 2024 |
